imetelstat sodium
imetelstat sodium is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including RYTELO. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- imetelstat sodium
- Brand Names
- RYTELO
- Application Number
- NDA217779
- Sponsor
- Geron Corporation
- NDC Codes
- 3
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- IMETELSTAT SODIUM
Indications and Usage
1. INDICATIONS AND USAGE RYTELO is indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA). RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA). ( 1 )